Dexcom Inc ($DXCM) Q3 2026 Earnings Call
Ladies and gentlemen thank you for standing by welcome to the Dexcom third quarter 2026 earnings release conference call my ...
Executive VP, CFO & Chief Accounting Officer, Dexcom
Verified interview transcripts, podcast appearances, and direct quotes from Jereme Sylvain, Executive VP, CFO & Chief Accounting Officer at Dexcom. AI-verified speaker identity with full-text searchable transcripts.
Ladies and gentlemen thank you for standing by welcome to the Dexcom third quarter 2026 earnings release conference call my ...
07/30/2025 Q&A: 18:34 DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital…
Jereme Sylvain, CFO at DexCom joins Bloomberg Radio to discuss DexCom's earnings and financial outlook. -------- Get more on The Tape Podcast On Apple: http://bit.ly/3YrBfOi On Spotify: http://bit.ly/3SPPZ8F Anywhere: http://bit.ly/43hOc0r
Sign in to search the full transcript archive, filter by topic, and access every quote from Jereme Sylvain.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans